Correlation Between Hillstream Biopharma and RenovoRx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hillstream Biopharma and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hillstream Biopharma and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hillstream Biopharma and RenovoRx, you can compare the effects of market volatilities on Hillstream Biopharma and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hillstream Biopharma with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hillstream Biopharma and RenovoRx.

Diversification Opportunities for Hillstream Biopharma and RenovoRx

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Hillstream and RenovoRx is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Hillstream Biopharma and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and Hillstream Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hillstream Biopharma are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of Hillstream Biopharma i.e., Hillstream Biopharma and RenovoRx go up and down completely randomly.

Pair Corralation between Hillstream Biopharma and RenovoRx

Given the investment horizon of 90 days Hillstream Biopharma is expected to under-perform the RenovoRx. But the stock apears to be less risky and, when comparing its historical volatility, Hillstream Biopharma is 1.5 times less risky than RenovoRx. The stock trades about -0.01 of its potential returns per unit of risk. The RenovoRx is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  271.00  in RenovoRx on August 27, 2024 and sell it today you would lose (142.00) from holding RenovoRx or give up 52.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy13.74%
ValuesDaily Returns

Hillstream Biopharma  vs.  RenovoRx

 Performance 
       Timeline  
Hillstream Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hillstream Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Hillstream Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
RenovoRx 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unfluctuating basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.

Hillstream Biopharma and RenovoRx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hillstream Biopharma and RenovoRx

The main advantage of trading using opposite Hillstream Biopharma and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hillstream Biopharma position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.
The idea behind Hillstream Biopharma and RenovoRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals